Effect of CYP2D6 polymorphism on Tamoxifen pharmacokinetic in Thai breast cancer patients
Thesis (M.Sc.)--Chulalongkorn University, 2011
Saved in:
Main Author: | Pichayapa Rungwanonchai (Author) |
---|---|
Other Authors: | Duanchit Panomvana na ayudhya (Contributor), Narin Voravud (Contributor), Chulalongkorn University. Faculty of Pharmaceutical Sciences (Contributor) |
Format: | Book |
Published: |
Chulalongkorn University,
2013-08-21T03:41:36Z.
|
Subjects: | |
Online Access: | http://cuir.car.chula.ac.th/handle/123456789/35675 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
by: Sirachainan E, et al.
Published: (2012) -
Association of CYP2D6 and CYP2C19 polymorphisms and disease-free survival of Thai post-menopausal breast cancer patients who received adjuvant tamoxifen
by: Chamnanphon M, et al.
Published: (2013) -
Association of CYP3A4/5, ABCB1 and ABCC2 polymorphisms and clinical outcomes of Thai breast cancer patients treated with tamoxifen
by: Sensorn I, et al.
Published: (2013) -
The Impact of CYP2D6 Genotyping on Tamoxifen Treatment
by: Roberta Ferraldeschi, et al.
Published: (2010) -
Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated with Tamoxifen
by: Werner Schroth, et al.
Published: (2017)